title: Rheumatoid arthritis clinical benefits from abatacept, cytokine blockers, and rituximab are all linked to modulation of memory B cell responses.
authors.affiliation: Departments of Medicine and Pathology;
authors.forename: Gregg J
authors.initials: GJ
authors.lastname: Silverman
authors.forename: Adam
authors.initials: A
authors.lastname: Pelzek
mesh_terms: D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology*; D001402:B-Lymphocytes / Q000276:immunology*; D005260:Female; D006801:Humans; D018796:Immunoconjugates / Q000008:administration & dosage*; D007136:Immunoglobulins / Q000276:immunology*; D007156:Immunologic Memory / Q000187:drug effects*; D008297:Male
chemical_list: D001323:Autoantibodies; D018796:Immunoconjugates; D007136:Immunoglobulins